Taken together, our data suggest that host deficiency in Cav-2 causes tumor regression in two independent syngeneic models of lung cancer growth in immunocompetent mice involving s.c. injection of LLC and CMT 167 lung carcinoma cells. The gene discussed is CAV2; the disease is lung cancer.